| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $13.0M | — | -48.8% |
| SG&A Expense | $5.9M | — | -0.1% |
| Operating Income | -$18.9M | — | +39.5% |
| Pre-tax Income | -$17.7M | — | +41.2% |
| Income Tax | $15K | — | — |
| Net Income | -$17.8M | — | +41.2% |
| EPS (Basic) | -$0.26 | — | +71.7% |
| EPS (Diluted) | -$0.26 | — | +71.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $42.1M | -30.3% | -3.4% |
| Short-term Investments | $90.2M | +2.5% | +66.5% |
| Current Assets | $134.3M | -11.1% | +32.9% |
| Total Assets | $156.3M | -10.1% | +22.7% |
| Current Liabilities | $9.0M | -29.1% | -56.1% |
| Total Liabilities | $22.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$18.4M | — | +19.6% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | -$1.5M | — | -108.5% |
| Financing Cash Flow | $1.5M | — | — |
| Free Cash Flow | -$18.4M | — | +20.1% |
| -37.3% |
| Stockholders' Equity | $134.0M | -9.1% | +45.9% |